These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 11384101)

  • 1. p53 mutations in urinary bladder cancer.
    Berggren P; Steineck G; Adolfsson J; Hansson J; Jansson O; Larsson P; Sandstedt B; Wijkström H; Hemminki K
    Br J Cancer; 2001 Jun; 84(11):1505-11. PubMed ID: 11384101
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific p53 gene mutations in urinary bladder epithelium after the Chernobyl accident.
    Yamamoto S; Romanenko A; Wei M; Masuda C; Zaparin W; Vinnichenko W; Vozianov A; Lee CC; Morimura K; Wanibuchi H; Tada M; Fukushima S
    Cancer Res; 1999 Aug; 59(15):3606-9. PubMed ID: 10446970
    [TBL] [Abstract][Full Text] [Related]  

  • 3. P53 mutations in colorectal cancer assessed in both genomic DNA and cDNA as compared to the presence of p53 LOH.
    Forslund A; Kressner U; Lönnroth C; Andersson M; Lindmark G; Lundholm K
    Int J Oncol; 2002 Aug; 21(2):409-15. PubMed ID: 12118339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p53 mutations as a marker of malignancy in bladder washing samples from patients with bladder cancer.
    Phillips HA; Howard GC; Miller WR
    Br J Cancer; 2000 Jan; 82(1):136-41. PubMed ID: 10638980
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Detection of loss of heterozygosity in the p53 tumor-suppressor gene with PCR in the urine of patients with bladder cancer.
    Friedrich MG; Erbersdobler A; Schwaibold H; Conrad S; Huland E; Huland H
    J Urol; 2000 Mar; 163(3):1039-42. PubMed ID: 10688045
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymerase chain reaction-based approaches for detection of allelic loss in the p53 tumor suppressor gene in colon neoplasms.
    Yamaguchi K; Sugano K; Fukayama N; Nakashima Y; Saotome K; Yokoyama T; Yokota T; Ohkura H
    Am J Gastroenterol; 1997 Feb; 92(2):307-12. PubMed ID: 9040212
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The study of p53 gene mutation in human bladder cancer].
    Ding Q; Zhang Y; Sun X
    Zhonghua Wai Ke Za Zhi; 1995 Nov; 33(11):684-6. PubMed ID: 8731915
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DNA polymerase beta gene mutations in human bladder cancer.
    Matsuzaki J; Dobashi Y; Miyamoto H; Ikeda I; Fujinami K; Shuin T; Kubota Y
    Mol Carcinog; 1996 Jan; 15(1):38-43. PubMed ID: 8561864
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P53 mutations as an identification marker for the clonal origin of bladder tumors and its recurrences.
    Dahse R; Gärtner D; Werner W; Schubert J; Junker K
    Oncol Rep; 2003; 10(6):2033-7. PubMed ID: 14534739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TP53 alterations as a potential diagnostic marker in superficial bladder carcinoma and in patients serum, plasma and urine samples.
    Dahse R; Utting M; Werner W; Schimmel B; Claussen U; Junker K
    Int J Oncol; 2002 Jan; 20(1):107-15. PubMed ID: 11743649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Improved clonality analysis of multifocal bladder tumors by combination of histopathologic organ mapping, loss of heterozygosity, fluorescence in situ hybridization, and p53 analyses.
    Denzinger S; Mohren K; Knuechel R; Wild PJ; Burger M; Wieland WF; Hartmann A; Stoehr R
    Hum Pathol; 2006 Feb; 37(2):143-51. PubMed ID: 16426913
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutation of the tumor suppressor gene p53 in human prostate and bladder cancers--investigation by temperature gradient gel electrophoresis (TGGE).
    Schlechte HH; Schnorr D; Löning T; Rudolph BD; Pohrt UM; Loening SA
    J Urol; 1997 Mar; 157(3):1049-53. PubMed ID: 9072541
    [TBL] [Abstract][Full Text] [Related]  

  • 13. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
    Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
    Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic implications of p53 gene mutations in bladder tumors.
    Lorenzo-Romero JG; Salinas-Sánchez AS; Giménez-Bachs JM; Sánchez-Sánchez F; Escribano-Martínez J; Segura-Martín M; Hernandez-Millán IR; Virseda-Rodríguez JA
    J Urol; 2003 Feb; 169(2):492-9. PubMed ID: 12544295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influence of cigarette smoking on P53 gene mutations in bladder carcinomas.
    Bernardini S; Adessi GL; Chezy E; Billerey C; Carbillet JP; Bittard H
    Anticancer Res; 2001; 21(4B):3001-4. PubMed ID: 11712801
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p14ARF promoter hypermethylation in plasma DNA as an indicator of disease recurrence in bladder cancer patients.
    Domínguez G; Carballido J; Silva J; Silva JM; García JM; Menéndez J; Provencio M; España P; Bonilla F
    Clin Cancer Res; 2002 Apr; 8(4):980-5. PubMed ID: 11948103
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distinct pattern of p53 mutations in bladder cancer: relationship to tobacco usage.
    Spruck CH; Rideout WM; Olumi AF; Ohneseit PF; Yang AS; Tsai YC; Nichols PW; Horn T; Hermann GG; Steven K
    Cancer Res; 1993 Mar; 53(5):1162-6. PubMed ID: 8439962
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Selective detection of inactivating mutations of the tumor suppressor gene p53 in bladder tumors.
    Pfister C; Flaman JM; Martin C; Grise P; Frebourg T
    J Urol; 1999 Jun; 161(6):1973-5. PubMed ID: 10332483
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tissue polypeptide antigen (TPA) in comparison with mutations of tumour suppressor gene P53 (TP53) in patients with bladder cancer.
    Ecke TH; Lenk SV; Schlechte HH; Loening SA
    Anticancer Res; 2003; 23(2A):957-62. PubMed ID: 12820330
    [TBL] [Abstract][Full Text] [Related]  

  • 20. LOH and mutational analysis of p53 alleles in mouse urinary bladder carcinomas induced by N-butyl-N-(4-hydroxybutyl) nitrosamine.
    Morimura K; Yamamoto S; Murai T; Mori S; Chen TX; Wanibuchi H; Fukushima S
    Carcinogenesis; 1999 Apr; 20(4):715-8. PubMed ID: 10223204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.